AuntMinnie.com staff writersRadiation Oncology/TherapyRayStation treatment planning added to Accuray's CyberKnifeRaySearch's RayStation treatment planning system has been integrated into the CyberKnife radiation therapy platform from radiation oncology firm Accuray.June 15, 2021MRIHealthcare veteran Huennekens joins HyperfinePortable MRI technology developer Hyperfine has appointed Scott Huennekens as executive chairman.June 15, 2021Radiologic TechnologistASRT Foundation awards $266K in scholarshipsThe American Society of Radiologic Technologists (ASRT) has awarded $265,500 in scholarships to 87 recipients for the 2021-2022 school year.June 15, 2021Nuclear MedicineSNMMI releases slate of officers for 2021-2022 termThe Society of Nuclear Medicine and Molecular Imaging (SNMMI) has released its slate of officers for its 2021-2022 term, headed by Dr. Richard Wahl as president.June 14, 2021Molecular ImagingAttralus touts amyloid imaging research at SNMMI 2021Biopharmaceutical company Attralus is directing attention to research presented this week at the annual meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI) involving its AT-01 amyloid imaging agent.June 14, 2021Nuclear MedicineRayzeBio nets over $100 million in Series C financingRadiopharmaceutical startup RayzeBio has received $108 million in series C financing to support its development of targeted radiopharmaceuticals for cancer treatment.June 14, 2021BreastKheiron brings Mia to Australia, New ZealandArtificial intelligence software developer Kheiron Medical Technologies has received clearance for its Mia mammography breast cancer screening software in Australia and New Zealand.June 14, 2021Molecular ImagingNew radiotracer visualizes protein key to cancer cell metabolismA team from Stanford University has used a new molecular imaging agent to visualize a protein critical to cancer cell metabolism, according to research presented June 14 at the virtual Society of Nuclear Medicine and Molecular Imaging 2021 annual meeting.June 14, 2021Nuclear MedicineNew PET tracer effective for imaging early Alzheimer's diseaseAustralian researchers found F-18 MK-6240 is a promising new PET tracer for detecting early pathology associated with Alzheimer's disease, according to research presented June 14 at the annual meeting of the Society of Nuclear Medicine and Molecular Imaging.June 14, 2021Molecular ImagingLantheus touts Pylarify clinical results at SNMMI 2021Lantheus Medical Imaging is highlighting clinical results from a phase III trial for its Pylarify (piflufolastat F-18) radiotracer that will be presented at the virtual 2021 Society of Nuclear Medicine and Molecular Imaging annual meeting.June 13, 2021Previous PagePage 249 of 3774Next PageTop StoriesBreastDBT performance improves with patient ageDBT led to higher cancer detection rates and lower abnormal interpretation rates in older women in a study over 93,000 women.Digital X-RayAI fails to compensate for night-shift fatigue among residentsPractice ManagementTrainee-led informed consent talks with patients often insufficientCTHigh CAC scores nearly doubles 30-year mortality in young adultsSponsor ContentFREE webinar: find your imaging capacity